Rocket One Inc. Proceeds from Issuance of Warrants
Rocket One Inc. (RKTO) reported Proceeds from Issuance of Warrants of $359.51 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2022-05-12
- Rocket One Inc. proceeds from issuance of warrants for the quarter ending 2021-12-31 was $0.00.
- Rocket One Inc. proceeds from issuance of warrants for the quarter ending 2021-09-30 was $0.00.
- Rocket One Inc. proceeds from issuance of warrants for the quarter ending 2021-06-30 was $768.00, a 95.90% decline year-over-year.
- Rocket One Inc. proceeds from issuance of warrants for the quarter ending 2021-03-31 was $358.75K, a 856.65% increase year-over-year.
- Rocket One Inc. proceeds from issuance of warrants for fiscal 2021 was $359.51K, a 539.13% increase from fiscal 2020.
- Rocket One Inc. proceeds from issuance of warrants for fiscal 2020 was $56.25K, a 34409.20% increase from fiscal 2019.
- Rocket One Inc. proceeds from issuance of warrants for fiscal 2019 was $163.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $768.00 derived: sum of 3 quarters · filed 2022-03-30 | $359.51K 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $768.00 derived: sum of 2 quarters · filed 2021-11-10 | $359.51K 10-Q · filed 2021-11-10 | $359.51K derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | $768.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $359.51K 10-Q · filed 2021-08-11 | $359.51K derived: sum of 3 quarters · filed 2022-05-12 | $359.51K derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | $358.75K 10-Q · filed 2022-05-12 | $358.75K derived: sum of 2 quarters · filed 2022-05-12 | $358.75K derived: sum of 3 quarters · filed 2022-05-12 | $377.50K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $18.75K derived: sum of 3 quarters · filed 2022-03-30 | $56.25K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $18.75K derived: sum of 2 quarters · filed 2021-11-10 | $56.25K 10-Q · filed 2021-11-10 | $56.25K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $18.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $56.25K 10-Q · filed 2021-08-11 | $56.25K derived: sum of 3 quarters · filed 2021-08-11 | $56.25K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $37.50K 10-Q · filed 2021-05-13 | $37.50K derived: sum of 2 quarters · filed 2021-05-13 | $37.50K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $163.00 10-K · filed 2021-03-16 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $163.00 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $163.00 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |